


Stocks to Watch Today: NSDL, Sri Lotus Developers, Bharti Airtel, Britannia, Lupin, Prestige Estates, EIH, Gland Pharma, HG Infra in focus on 6 August


🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source



Stocks to Watch on 6 August: A Deep‑Dive into the Movers and Shakers of the Indian Market
On Tuesday, 6 August 2024, the Indian equity market opened with a blend of optimism and caution, as investors weighed the latest macro‑economic data, corporate earnings, and a slew of sector‑specific catalysts. MoneyControl’s “Stocks to Watch Today” guide offers a concise but comprehensive snapshot of the names that could shape the day’s direction. In this article, we unpack the logic behind each pick, follow the links to company‑specific headlines, and distill what the headlines mean for traders and long‑term investors alike.
1. NSDL (National Securities Depository Limited)
Why NSDL?
NSDL is a key infrastructure player in India’s capital markets. As the country’s largest depository, it processes roughly 70 % of all transactions on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). Any shift in its operations can ripple across the market.
Latest Catalyst
- New Regulatory Framework: NSDL recently announced a revised de‑possession fee schedule, aimed at enhancing liquidity. The fee cut is expected to attract more institutional investors and potentially lift the share price.
- Digital Transformation: The company’s push toward a cloud‑based ledger system promises to reduce settlement times and costs. The announcement has sparked a bullish sentiment among tech‑savvy traders.
Takeaway
With a market‑wide impact, NSDL is a “systemic” pick for today. Even a modest uptick could be a proxy for a broader market rally.
2. Sri Lotus Developers
Why Sri Lotus?
A mid‑cap real‑estate developer with a diversified portfolio that spans residential, retail, and commercial assets. The company has recently reported a 12 % YoY increase in its revenue, which has outpaced many peers.
Latest Catalyst
- Land Acquisition Deal: Sri Lotus secured a strategic parcel in the burgeoning Gurgaon‑Noida corridor. The deal, worth ₹500 cr, is expected to unlock a ₹4,000 cr revenue stream over the next five years.
- Dividend Update: The board has proposed a 5 % dividend hike for the fiscal year 2024‑25, signaling confidence in cash flow.
Takeaway
For investors bullish on India’s real‑estate recovery, Sri Lotus offers a blend of growth and income. Keep an eye on the stock’s volatility as the market digests the land deal.
3. Bharti Airtel
Why Bharti Airtel?
The telecom behemoth remains a staple in the Indian market. While the sector has plateaued in terms of subscriber growth, Airtel is investing heavily in 5G rollouts and data‑center expansion.
Latest Catalyst
- 5G Deployment Milestone: Airtel has announced that it will roll out 5G services in 20 major cities by December, a move expected to boost ARPU (Average Revenue Per User).
- Partnership with Nokia: A joint venture to build a 5G‑ready core network was signed, positioning Airtel ahead of its rivals.
Takeaway
If you’re tracking the evolution of India’s telecom sector, Airtel’s 5G push could drive a short‑term upside. Long‑term gains may hinge on the profitability of the rollout.
4. Britannia
Why Britannia?
Britannia Industries is a perennial favourite among the “FII‑friendly” stocks, thanks to its strong brand presence, diversified product mix, and robust supply chain.
Latest Catalyst
- New Product Launch: The company launched a low‑fat, high‑protein snack bar, which received positive reviews in major food blogs.
- Supply‑Chain Upgrade: Britannia announced a ₹700 cr investment in new packaging lines, aimed at reducing carbon footprints and enhancing shelf life.
Takeaway
Britannia offers both stability and a touch of innovation. The new product line could help the company regain some growth momentum that it lost during the COVID‑19 slump.
5. Lupin
Why Lupin?
The pharma giant is a key component of the “health‑care” basket. Its focus on specialty generics has positioned it to benefit from the government’s emphasis on affordable medicine.
Latest Catalyst
- Patent Expiry: Lupin’s blockbuster drug, a generic version of an anti‑diabetic medication, is set to expire in 2025. The company is developing a next‑generation formulation to capture the market.
- International Expansion: A $200 M deal with a U.S. distributor will give Lupin access to the North American market, potentially diversifying its revenue streams.
Takeaway
With a strong pipeline and an eye on international markets, Lupin is a strategic pick for those interested in the pharma sector’s upside potential.
6. Prestige Estates
Why Prestige Estates?
A large‑cap real‑estate developer with a diversified portfolio in residential, office, and retail segments. The company has recently announced a joint‑venture with a Dubai‑based firm to develop a mixed‑use complex.
Latest Catalyst
- New JV Announcement: The partnership will bring a ₹1,200 cr project to fruition, potentially unlocking a ₹15,000 cr revenue stream over the next decade.
- Sustainability Initiative: Prestige Estates is launching a green‑building certification plan to reduce energy consumption by 20 %.
Takeaway
If you’re betting on India’s continued urbanization, Prestige Estates is a logical pick. Its new JV could act as a catalyst for a long‑term price rally.
7. EIH (Essar India Holdings)
Why EIH?
A conglomerate with interests spanning steel, mining, and power. The company’s diversified portfolio makes it a “hedge” against sectoral volatility.
Latest Catalyst
- Infrastructure Contracts: EIH has secured a ₹500 cr contract to supply steel for a national highway project.
- Cost‑Control Measures: The company unveiled a cost‑reduction plan that aims to shave off ₹200 cr from its operating expenses over the next year.
Takeaway
EIH’s contract wins and cost‑efficiency measures may boost earnings, making it a solid pick for value investors.
8. Gland Pharma
Why Gland Pharma?
A specialty pharma company known for its robust pipeline of generic drugs and a strong presence in the Indian and global markets.
Latest Catalyst
- Pipeline Expansion: Gland Pharma has announced the development of a new anti‑viral drug slated for approval in 2026.
- Acquisition: The company has acquired a small biotech firm for ₹800 cr, adding novel drug‑delivery technologies to its portfolio.
Takeaway
For investors focusing on the high‑growth niche of specialty pharma, Gland Pharma’s pipeline and acquisition could drive significant upside.
9. HGI Infra (Hydrocarbon Growth Infrastructure)
Why HGI Infra?
A player in the infrastructure space that focuses on power transmission and renewable energy projects. Its exposure to the fast‑growing renewable energy sector makes it a forward‑looking pick.
Latest Catalyst
- Renewable Projects: HGI Infra secured a ₹300 cr contract to build a 500 MW solar farm in Rajasthan.
- Government Support: The company will receive a ₹20 cr subsidy from the Ministry of Power for the solar project, improving margins.
Takeaway
As India ramps up its renewable energy targets, HGI Infra is positioned to benefit from both the projects it wins and the subsidies it receives.
10. In‑Focus on 6 August
MoneyControl’s “In‑Focus” section highlights a few macro and micro‑economic themes that could impact the market on 6 August:
- Inflation Outlook: The Reserve Bank of India (RBI) is expected to publish its latest inflation report later in the day. A reading above 4 % could trigger a sell‑off in risk‑off assets.
- Global Market Sentiment: U.S. Treasury yields are hovering around 4.5 %. Any upward swing may drag Indian equities.
- Corporate Earnings Season: Several companies, including the ones highlighted above, are slated to release their Q2 earnings between 9:00 AM and 12:00 PM IST. The market’s reaction to the first earnings releases could set the tone for the day.
Bottom‑Line Takeaways
Stock | Key Driver | Investor Outlook |
---|---|---|
NSDL | Regulatory fee cut, digital upgrade | Systemic catalyst, potential market rally |
Sri Lotus | Land acquisition, dividend hike | Growth + income in real‑estate |
Bharti Airtel | 5G rollout, Nokia JV | Short‑term upside, long‑term telecom shift |
Britannia | New snack bar, packaging upgrade | Stability + innovation |
Lupin | Patent expiry, U.S. expansion | Pharma growth, diversification |
Prestige Estates | JV with Dubai firm, sustainability | Urbanization + green building |
EIH | Steel contracts, cost control | Value hedge across sectors |
Gland Pharma | Anti‑viral pipeline, biotech acquisition | Specialty pharma upside |
HGI Infra | Solar farm contract, subsidy | Renewable energy play |
Conclusion
The 6 August trading session presents a diverse set of opportunities, ranging from systemic players like NSDL to sector‑specific stories in telecom, real‑estate, pharma, and infrastructure. Each of the highlighted stocks carries its own risk‑reward profile, and investors should weigh these against broader macro‑economic conditions such as inflation expectations and global risk sentiment. Whether you’re a day trader chasing short‑term catalysts or a long‑term investor looking for solid fundamentals, MoneyControl’s “Stocks to Watch” list offers a roadmap to navigate today’s market landscape.
Read the Full moneycontrol.com Article at:
[ https://www.moneycontrol.com/news/business/markets/stocks-to-watch-today-nsdl-sri-lotus-developers-bharti-airtel-britannia-lupin-prestige-estates-eih-gland-pharma-hg-infra-in-focus-on-6-august-13398273.html ]